Scientific study: Countries that have an anti-tuberculosis vaccinate have fewer deaths than coronarys

Such a distinction in figures on the Iberian Peninsula is mysterious, but in part it could be explained by two different ways of using vaccines in these countries. Not the use of a coronary vaccine, because it still does not exist, but the use of a tuberculosis vaccine, which exists for decades, should provide an explanation.
A new scientific study has revealed possible linkage between countries where tuberculosis vaccination is binding and the influence of the new coronary.
“We have found that states without general policies for BCG vaccine (Baccillus Calmette-Guerer), such as Italy, Holland and the United States, have been more affected than states that have universal and long-term policies for BCG<x1) vaccine, the study says.
“There have been reports that BCG vaccine can provide broad protection against respiratory organ infections”. said Gonzalo Otzazu, a researcher at the New York Institute for Technology and one of the authors of the study.
We looked at the data. States that had never implemented universal policies for BCG vaccines were being more affected by the coronary and had higher deaths per head, he added.
Otazu compared policies in states where anti-tuberculosis has been universally implemented and states where it has not been implemented.
Italy, the country with the most victims of the coronary, has never implemented universal vaccine against tuberculosis.
Japan, which has far fewer fatal cases and has taken milder measures of isolation, has a universal vaccine policy against tuberculosis.
Researchers also compared Japan to Iran. Both countries have implemented universal vaccines with BCG, but at different times.
Japan began using this vaccine universally in 1947, and Iran in 1984. Japan has about 100 deaths less for a million people than Iran.
The “States that started the ovarian use of the BCG vaccine later had higher death rates”, researchers said.
This research also explains the difference between the impact of coronary in Western Europe and Eastern Europe, because policies for universal inoculation against tuberculosis have been more common in countries of the former Soviet Union.
East Germany regions, which were part of East Germany until 1989, have the smallest number of coronary cases for 100,000 inhabitants, according to Institute “data Robert Koch” Camille Guerin and Albert Callette, BCG vaccine detectors
French scientists had begun the discovery of the BCG vaccine in 1908, while the first human test had begun in 1921. The name BCG, or Bacillus Calmette-Guer, was taken from scientists' surnames Albert Calmette and Camille Guer.

The BCG vaccine is part of the vaccine protocol in Kosovo as well. This vaccine is given to babies in their early days and then back to age 6 or 7. / Translate: Nasuf Abdel